1st Speaker

Non-Pharmacological Treatment of Agitation in Dementia

Janette Leal, M.D.

2nd Speaker

Neurocognitive Difficulties among Adolescents/Young Adults with POTS:  Subjective Experiences and Objectively Measured Weaknesses

Michele Tsai Owens, Ph.D.

Introduction

1st Speaker

Dr. Janette Leal, MD is currently a part time Geriatric Psychiatry fellow and part time psychiatry consultant. She obtained her medical degree at Saint James School of Medicine in the Netherland Antilles and completed and combined Internal Medicine and Psychiatry residency at the University of Iowa. She has become particularly passionate about Geriatric psychiatry and looks forward to the rest of her career.

2nd Speaker

Dr. Michele Tsai Owens is a second-year Clinical Child/Pediatric Psychology Fellow at Mayo Clinic. She received her B.A. degrees in Psychology and Philosophy-Neuroscience-Psychology from Washington University in St. Louis. She earned her M.A. and Ph.D. degrees in Clinical Psychology from the University of Kansas and completed a Pre-doctoral Pediatric Psychology Internship at the University of Minnesota Medical Center. Dr. Tsai Owens’ clinical and research interests include pediatric patients’ adaptation to and management of chronic medical conditions.

Learning Objectives

1st Speaker

1. Identify signs of early agitation.
2. Identify non-pharmacological alternatives of treatment.
3. Identify risk of medication use for behavioral decontrol in the elderly.

2nd Speaker

1. Describe the prevalence of subjectively experienced neurocognitive difficulties among pediatric patients with POTS.
2. Describe the prevalence of weaknesses in attention/working memory and memory among these patients.
3. Recognize relative contributions of POTS symptoms, co-occurring pain, and affective symptoms to neurocognitive functioning among these patients.

Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu.

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.

Disclosure Summary
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D. - Mayo Clinic

Grant Support: AssureRx, Janssen R&D, Myriad, Pfizer Consultant: Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel: American Physician Institute, CME Outfitters

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

Speakers: Janette Leal, M.D and Michele Tsai Owens, Ph.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation: NONE